The World Bank Working for a World Free of Poverty Microdata Library
  • Data Catalog
  • About
  • Collections
  • Citations
  • Terms of use
  • Login
    Login
    Home / Central Data Catalog / IMPACT_EVALUATION / BEN_2010_HRBF_V01_M_V01_A_PUF / variable [F71]
impact_evaluation

Health Results-Based Financing Impact Evaluation Survey 2010-2011, Baseline

Benin, 2010 - 2011
Get Microdata
Reference ID
BEN_2010_HRBF_v01_M_v01_A_PUF
DOI
https://doi.org/10.48529/qkmg-r734
Producer(s)
Christophe Lemière and Damien de Walque
Collection(s)
Impact Evaluation Surveys
Metadata
Documentation in PDF DDI/XML JSON
Created on
Oct 20, 2014
Last modified
Oct 21, 2014
Page views
686988
Downloads
17274
  • Study Description
  • Data Description
  • Documentation
  • Get Microdata
  • Data files
  • benhrbf2_d
  • benhrbf2_d2_tab21
  • benhrbf2_d2_tab22
  • benhrbf2_d2_tab25
  • benhrbf2_d7_tab71
  • benhrbf2_d8_tab811
  • benhrbf2_d8_tab812
  • benhrbf2_d8_tab813
  • benhrbf2_d8_tab814
  • benhrbf2_d8_tab815
  • benhrbf2_d8_tab816
  • benhrbf2_e1_6
  • benhrbf2_e1_11
  • benhrbf2_e2_q1
  • benhrbf2_e2_q20
  • benhrbf2_e3_0a
  • benhrbf2_e3_0b
  • benhrbf2_e3_0c
  • benhrbf2_e5_5_6
  • benhrbf2_e5_5_7
  • benhrbf2_e13_tab_131
  • benhrbf2_e13_tab_132
  • benhrbf2_e13_tab_133
  • benhrbf2_e13_tab_134
  • benhrbf2_e13_tab_135
  • benhrbf2_e13_tab_139
  • benhrbf2_e13_tab_1310
  • benhrbf2_f
  • benhrbf2_g
  • benhrbf2_g1
  • benhrbf2_h
  • benhrbf2_h6_1
  • benhrbf2_h6_2
  • benhrbf2_h7
  • benhrbf2_h8
  • benhrbf2_i
  • benhrbf2_i1_tabq26
  • benhrbf2_j
  • benhrbf2_k
  • benhrbf2_k2_1
  • benhrbf2_k2_2
  • benhrbf2_k2_3_d
  • benhrbf2_k3_1
  • benhrbf2_k3_2
  • benhrbf2_k3_3
  • benhrbf2_l
  • benhrbf2_l5
  • benhrbf2_m
  • benhrbf2_n
  • benhrbf2_ntab_n5_1
  • benhrbf2_ntab_n5_31
  • benhrbf2_ntab_n5_61
  • benhrbf2_ntab_n6_41
  • benhrbf2_ntab_n8_8
  • benhrbf2_ntab_n8_10
  • benhrbf2_ntab_n8_22
  • benhrbf2_ntab_n8_32
  • benhrbf2_ntab_n8_53
  • benhrbf2_o
  • benhrbf2_o6_tabq62
  • benhrbf2_o6_tabq64
  • benhrbf2_o6_tabq69
  • benhrbf2_o6_tabq611
  • benhrbf2_p
  • benhrbf2_p_7_tabq72
  • benhrbf2_p_8
  • benhrbf2_p_9
  • benhrbf2_p_10
  • benhrbf2_q_15b
  • benhrbf2_r
  • benhrbf2_r_tab_r5_1
  • benhrbf2_r_tab_r5_31
  • benhrbf2_r_tab_r5_61
  • benhrbf2_r_tab_r6_41
  • benhrbf2_r_tab_r8_8
  • benhrbf2_r_tab_r8_10
  • benhrbf2_r_tab_r8_22
  • benhrbf2_r_tab_r8_32
  • benhrbf2_r_tab_r8_53
  • benhrbf2_s
  • benhrbf2_s_tab1_3_1
  • benhrbf2_s_tab2_13
  • benhrbf2_tab_f2_6
  • benhrbf2_tab_f2_7
  • benhrbf2_tab_f2_8
  • benhrbf2_tab_f2_9
  • benhrbf2_tab_f2_34
  • benhrbf2_tab_f2_35
  • benhrbf2_tab_f2_36
  • benhrbf2_tab_f2_37
  • benhrbf2_tab_f2_38
  • benhrbf2_tab_f2_39
  • benhrbf2_tab_f2_40
  • benhrbf2_tab_f2_41
  • benhrbf2_tab_f2_42
  • benhrbf2_tab_f3_36b
  • benhrbf2_tab_f3_36c
  • benhrbf2_tab_f3_42
  • benhrbf2_tab_f3_43
  • benhrbf2_tab_f3_44
  • benhrbf2_tab_f4_1
  • benhrbf2_tab_f6
  • benhrbf2_tab_f7
  • benhrbf2_d_2_tab21_control
  • benhrbf2_d_2_tab22_control
  • benhrbf2_d_2_tab25_control
  • benhrbf2_d_7_tab71_control
  • benhrbf2_d_8_tab811_control
  • benhrbf2_d_8_tab812_control
  • benhrbf2_d_8_tab813_control
  • benhrbf2_d_8_tab814_control
  • benhrbf2_d_8_tab815_control
  • benhrbf2_d_8_tab816_control
  • benhrbf2_d_control
  • benhrbf2_e1_6_control
  • benhrbf2_e1_11_control
  • benhrbf2_e2_q1_control
  • benhrbf2_e2_q20_control
  • benhrbf2_e3_0a_control
  • benhrbf2_e3_0b_control
  • benhrbf2_e3_0c_control
  • benhrbf2_e5_5_6_control
  • benhrbf2_e5_5_7_control
  • benhrbf2_e13_tab131_control
  • benhrbf2_e13_tab132_control
  • benhrbf2_e13_tab133_control
  • benhrbf2_e13_tab134_control
  • benhrbf2_e13_tab135_control
  • benhrbf2_e13_tab139_control
  • benhrbf2_e13_tab1310_control
  • benhrbf2_e_control
  • benhrbf2_f_control
  • benhrbf2_f_tab2_6_control
  • benhrbf2_f_tab2_7_control
  • benhrbf2_f_tab2_8_control
  • benhrbf2_f_tab2_9_control
  • benhrbf2_f_tab2_34_control
  • benhrbf2_f_tab2_35_control
  • benhrbf2_f_tab2_36_control
  • benhrbf2_f_tab2_37_control
  • benhrbf2_f_tab2_38_control
  • benhrbf2_f_tab2_39_control
  • benhrbf2_f_tab2_40_control
  • benhrbf2_f_tab2_41_control
  • benhrbf2_f_tab2_42_control
  • benhrbf2_f_tab3_36b_control
  • benhrbf2_f_tab3_36c_control
  • benhrbf2_f_tab3_42_control
  • benhrbf2_f_tab3_43_control
  • benhrbf2_f_tab3_44_control
  • benhrbf2_f_tab4_1_control
  • benhrbf2_f_tab6_control
  • benhrbf2_f_tab7_control
  • benhrbf2_g1_control
  • benhrbf2_g_control
  • benhrbf2_h_6_1_control
  • benhrbf2_h_6_2_control
  • benhrbf2_h_7_control
  • benhrbf2_h_8_control
  • benhrbf2_h_control
  • benhrbf2_i1_tabq26_control
  • benhrbf2_i_control
  • benhrbf2_j_control
  • benhrbf2_k2_1_control
  • benhrbf2_k2_2_control
  • benhrbf2_k3_1_control
  • benhrbf2_k3_2_control
  • benhrbf2_k3_3_control
  • benhrbf2_k_control
  • benhrbf2_l5_control
  • benhrbf2_l_control
  • benhrbf2_m_control
  • benhrbf2_n_control
  • benhrbf2_n_tab5_1_control
  • benhrbf2_n_tab5_31_control
  • benhrbf2_n_tab5_61_control
  • benhrbf2_n_tab6_41_control
  • benhrbf2_n_tab8_8_control
  • benhrbf2_n_tab8_10_control
  • benhrbf2_n_tab8_22_control
  • benhrbf2_n_tab8_32_control
  • benhrbf2_n_tab8_53_control
  • benhrbf_o_6_tabq62_control
  • benhrbf_o_6_tabq64_control
  • benhrbf_o_6_tabq69_control
  • benhrbf_o_6_tabq611_control
  • benhrbf_o_control
  • benhrbf_p_7_tabq72_control
  • benhrbf_p_8_control
  • benhrbf_p_9_control
  • benhrbf_p_10_control
  • benhrbf_p_control
  • benhrbf_q_15b_control
  • benhrbf_q_15c_control
  • benhrbf_q_control
  • benhrbf2_r_control
  • benhrbf2_r_tab5_1_control
  • benhrbf2_r_tab5_31_control
  • benhrbf2_r_tab5_61_control
  • benhrbf2_r_tab6_41_control
  • benhrbf2_r_tab8_8_control
  • benhrbf2_r_tab8_10_control
  • benhrbf2_r_tab8_22_control
  • benhrbf2_r_tab8_32_control
  • benhrbf2_r_tab8_53_control
  • benhrbf2_s_1_tab31_control
  • benhrbf2_s_2_tab13_control
  • benhrbf2_s_control
  • benHRBF_A-00
  • benHRBF_A-01
  • benHRBF_A-02
  • benHRBF_A-03
  • benHRBF_A-04
  • benHRBF_A-05
  • benHRBF_A-06
  • benHRBF_A-07
  • benHRBF_A-08
  • benHRBF_A-09
  • benHRBF_A-10
  • benHRBF_A-11
  • benHRBF_A-12
  • benHRBF_A-13
  • benHRBF_B-00
  • benHRBF_B-01
  • benHRBF_B-02
  • benHRBF_B-03
  • benHRBF_B-04
  • benHRBF_B-05
  • benHRBF_B-06
  • benHRBF_B-07
  • benHRBF_B-08
  • benHRBF_B-09
  • benHRBF_B-10
  • benHRBF_C-00
  • benHRBF_C-01
  • benHRBF_C-02
  • benHRBF_C-03
  • benHRBF_C-04
  • benHRBF_C-05
  • benHRBF_C-06
  • benHRBF_A-00_control
  • benHRBF_A-01_control
  • benHRBF_A-02_control
  • benHRBF_A-03_control
  • benHRBF_A-04_control
  • benHRBF_A-05_control
  • benHRBF_A-06_control
  • benHRBF_A-07_control
  • benHRBF_A-08_control
  • benHRBF_A-09_control
  • benHRBF_A-10_control
  • benHRBF_A-11_control
  • benHRBF_A-12_control
  • benHRBF_A-13_control
  • benHRBF_B-00_control
  • benHRBF_B-01_control
  • benHRBF_B-02_control
  • benHRBF_B-03_control
  • benHRBF_B-04_control
  • benHRBF_B-05_control
  • benHRBF_B-06_control
  • benHRBF_B-07_control
  • benHRBF_B-08_control
  • benHRBF_B-09_control
  • benHRBF_B-10_control
  • benHRBF_C-00_control
  • benHRBF_C-01_control
  • benHRBF_C-02_control
  • benHRBF_C-03_control
  • benHRBF_C-04_control
  • benHRBF_C-05_control
  • benHRBF_C-06_control
  • benhrbf2_e
  • benhrbf2_q
  • benhrbf_q_control

libelle 15.19 ... (e15_lib1519)

Data file: benhrbf2_q_15b

Overview

Valid: 18425
Invalid: 0
Type: Discrete
Start: 10
End: 39
Width: 30
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
15.19. Antibiotiques : Cet éta 125
0.7%
15.19.1 Amoxicilline 122
0.7%
15.19.10 Cloxacilline sodique 122
0.7%
15.19.11 Doxycycline 122
0.7%
15.19.12 Érythromycine 122
0.7%
15.19.13 Flucloxacilline par v 122
0.7%
15.19.15 Gentamicine (injectab 122
0.7%
15.19.15 Nétilmicine (Nétromic 122
0.7%
15.19.16 Métronidazole (inject 122
0.7%
15.19.17 Pénicilline G (Benzyl 122
0.7%
15.19.18 Benzylpénicilline pro 122
0.7%
15.19.19 Triméthoprime/Sulfamé 122
0.7%
15.19.2 Ampicilline 122
0.7%
15.19.20 Collyre antiseptique 122
0.7%
15.19.3 Céfazoline sodique 122
0.7%
15.19.4 Céfixime 122
0.7%
15.19.5 Ceftriaxone 122
0.7%
15.19.6 Cefotaxime injectable 122
0.7%
15.19.7 Chloramphénicol (injec 122
0.7%
15.19.8 Ciprofloxacine (Inject 122
0.7%
15.19.9 Clindamycine 122
0.7%
15.20. Anticonvulsivants : Cet 122
0.7%
15.20.1 Sulfate de magnésium 5 122
0.7%
15.20.2 Sulfate de magnésium ( 122
0.7%
15.20.3 Diazépam (injectable) 122
0.7%
15.20.4 Midazolam injectable 122
0.7%
15.20.5 Phénobarbital (injecta 122
0.7%
15.20.6 Phénytoïne (diphénylhy 122
0.7%
15.21. Antihypertenseurs : Cet 122
0.7%
15.21.1 Clonidine (injectable) 122
0.7%
15.21.10 Misoprostol (Cytotec) 122
0.7%
15.21.11 Oxytocine 122
0.7%
15.21.12 Prostaglandine E2 (di 122
0.7%
15.21.2 Hydralazine (injectabl 122
0.7%
15.21.3 Hydrochlorothiazide (C 122
0.7%
15.21.4 Labétalol (injectable) 122
0.7%
15.21.5 Atenolol (Comp.) 122
0.7%
15.21.6 Méthyldopa (Comp.) 122
0.7%
15.21.7 Nifédipine (Comp.) 122
0.7%
15.21.8 Nicardipine (injectabl 122
0.7%
15.21.9 Méthylergométrine 122
0.7%
15.22. Médicaments d’urgence : 122
0.7%
15.22.1 Adrénaline (épinéphrin 122
0.7%
15.22.10 Hydrocortisone 122
0.7%
15.22.11 Naloxone 122
0.7%
15.22.12 Flumazénil 122
0.7%
15.22.13 Prostigmine 122
0.7%
15.22.15 Nitroglycérine 122
0.7%
15.22.15 Prométhazine 122
0.7%
15.22.16 Chlorure de potassium 122
0.7%
15.22.17 Chlorure de sodium 122
0.7%
15.22.2 Nor Adrénaline (Norépi 122
0.7%
15.22.3 Aminophylline 122
0.7%
15.22.4 Atropine 122
0.7%
15.22.5 Gluconate de Calcium 122
0.7%
15.22.6 Digoxine 122
0.7%
15.22.7 Diphénhydramine 122
0.7%
15.22.8 Éphédrine 122
0.7%
15.22.9 Furosémide 122
0.7%
15.23 Anesthésiques : Cet étab 122
0.7%
15.23.1 Halothane 122
0.7%
15.23.2 Isoflurane 122
0.7%
15.23.3 Kétamine 122
0.7%
15.23.4 Thiopental 122
0.7%
15.24. Curares : Cet établisse 122
0.7%
15.24.1 Suxaméthonium 122mg (i 122
0.7%
15.24.2 Bromure de vécuronium 122
0.7%
15.25. Anesthésiques locaux : 122
0.7%
15.25.1 Lidocaïne 2 % ou 1 % 122
0.7%
15.25.2 Bupivacaïne 2,5% normo 122
0.7%
15.25.3 Bupivacaïne 2,5% hyper 122
0.7%
15.26. Analgésiques : Cet étab 122
0.7%
15.26.1 Acide acétyl salicyliq 122
0.7%
15.26.2 Indométacine 122
0.7%
15.26.3 Morphine 122
0.7%
15.26.4 Paracétamol 122
0.7%
15.26.5 Métamizole/ Analgin/ N 122
0.7%
15.26.6 Péthidine 122
0.7%
15.26.7 Fentanyl 2,5mg : 522mc 122
0.7%
15.26.8 Sufentanyl 12mcg et 52 122
0.7%
15.27. Tocolytiques : Cet étab 122
0.7%
15.27.1 Ritodrine 122
0.7%
15.27.2 Salbutamol 122
0.7%
15.28. Corticoïdes : Cet établ 122
0.7%
15.28.1 Bétaméthasone 122
0.7%
15.28.2 Prednisolone 122
0.7%
15.28.2 Prednisone 122
0.7%
15.29. Solutés intraveineux : 122
0.7%
15.29.1 Dextran 122
0.7%
15.29.2 Glucose 5 % 122
0.7%
15.29.3 Glucose 10 % 122
0.7%
15.29.4 Glucose 30% 122
0.7%
15.29.5 Sérum salé 9/1000 122
0.7%
15.29.6 Ringer lactate 122
0.7%
15.29.7 Serum Bicarbonate 15/1 122
0.7%
15.30. Antipaludiques : Cet ét 122
0.7%
15.30.1 Combinaisons Thérapeut 122
0.7%
15.30.2 Test de diagnostique r 122
0.7%
15.30.3 Quinine dihydrochlorid 122
0.7%
15.30.3 Sulfadoxine pyrimétham 122
0.7%
15.30.4 Fer acide folique 122
0.7%
15.30.5 Vitamine A 122
0.7%
15.30.6 Albambazole 122
0.7%
15.30.7 Mebeldazole 122
0.7%
15.30.8 Moustiquaire imprégnée 122
0.7%
15.31. Antirétroviraux : Cet é 122
0.7%
15.31.1 Névirapine comprimé 122
0.7%
15.31.10 Triomine (3TC, D4T, N 122
0.7%
15.31.11 Nelfinavir gelule 122
0.7%
15.31.12 Nelfinavir Suspension 122
0.7%
15.31.13 Kaletra comprimé (Lop 122
0.7%
15.31.15 Efavirenz comprimé 122
0.7%
15.31.15 Kaletra suspension bu 122
0.7%
15.31.2 Nevirapine Suspension 122
0.7%
15.31.3 Duovir (AZT+3TC) compr 122
0.7%
15.31.4 AZT (Zidovudine) compr 122
0.7%
15.31.5 AZT (Zidovudine) Suspe 122
0.7%
15.31.6 Lamividine (3TC) compr 122
0.7%
15.31.7 Lamividine (3TC) Suspe 122
0.7%
15.31.8 Stavudine (D4T) compri 122
0.7%
15.31.9 Stavudine (D4T) Suspen 122
0.7%
15.32. Contraceptifs : Cet éta 122
0.7%
15.32.1 Contraceptifs oraux co 122
0.7%
15.32.2 Implants 122
0.7%
15.32.3 DIU 122
0.7%
15.32.4 Equilibre 122
0.7%
15.32.5 Noristérat 122
0.7%
15.32.6 Pilule Progestative (O 122
0.7%
15.32.7 Préservatifs masculins 122
0.7%
15.32.8 Préservatifs féminins 122
0.7%
15.32.9 Contraception d’urgenc 122
0.7%
15.33 Autres médicaments Les m 122
0.7%
15.33.1 Vitamine K1 naturelle 122
0.7%
15.33.10 Enoxaparine sodique 4 122
0.7%
15.33.11 Trisilicate de magnés 122
0.7%
15.33.12 Citrate de sodium 122
0.7%
15.33.13 Sérum antitétanique 122
0.7%
15.33.15 Vaccin BCG 122
0.7%
15.33.15 Vaccin antitétanique 122
0.7%
15.33.16 Vaccin Polio 122
0.7%
15.33.17 Vaccin VTE 122
0.7%
15.33.18 Immunoglobulines anti 122
0.7%
15.33.19 Immunoglobulines anti 122
0.7%
15.33.2 Métronidazole ovule 122
0.7%
15.33.3 Nystatine ovule 122
0.7%
15.33.4 Nystatine (voie orale) 122
0.7%
15.33.5 Solution de réhydratat 122
0.7%
15.33.6 Violet de Gentiane 122
0.7%
15.33.7 Sulfate ferreux ou fum 122
0.7%
15.33.8 Acide folique 122
0.7%
15.33.9 Héparine 122
0.7%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
The World Bank Working for a World Free of Poverty
  • IBRD IDA IFC MIGA ICSID

© The World Bank Group, All Rights Reserved.

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.